SCHEMBL24443875

SCHEMBL24443875

CC1=C/C(=N/c2ccc(C)cc2)C(C)=CC1=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PABPC1 P11940 1/20 0.44
▸ MAPT P10636 6/20 0.41
▸ ALDH1A1 P00352 4/20 0.41
▸ LMNA P02545 3/20 0.41
▸ RAB9A P51151 3/20 0.41
▸ MPI P34949 2/20 0.41
▸ S1PR2 O95136 1/20 0.41
▸ HSP90AA1 P07900 1/20 0.41
▸ XBP1 P17861 1/20 0.41
▸ OPRM1 P35372 1/20 0.41
▸ OPRD1 P41143 1/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.41
▸ PLK1 P53350 2/20 0.39
▸ PLK2 Q9NYY3 2/20 0.39
▸ HPGD P15428 2/20 0.38
▸ NPC1 O15118 2/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ EEF2K O00418 1/20 0.35
▸ TTR P02766 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13525199 0.85 PABPC1 (0.41) PABPC1MAPTALDH1A1LMNARAB9A
SCHEMBL11787610 0.85 PABPC1 (0.41) PABPC1MAPTALDH1A1LMNARAB9A
SCHEMBL16983992 0.84 PABPC1 (0.41) PABPC1MAPTALDH1A1LMNARAB9A
SCHEMBL17289456 0.84 PABPC1 (0.41) PABPC1MAPTALDH1A1LMNARAB9A
SCHEMBL17289455 0.84 PABPC1 (0.41) PABPC1MAPTALDH1A1LMNARAB9A
SCHEMBL11309468 0.82 PABPC1 (0.67) PABPC1MAPTALDH1A1LMNARAB9A
SCHEMBL11629876 0.75 PABPC1 (0.43) PABPC1MAPTALDH1A1LMNARAB9A
SCHEMBL10782928 0.73 PABPC1 (0.41) PABPC1MAPTALDH1A1RAB9ANPC1
SCHEMBL24443643 0.73 PABPC1 (0.37) PABPC1MAPTALDH1A1LMNARAB9A
SCHEMBL24514478 0.73 PABPC1 (0.37) PABPC1MAPTALDH1A1LMNARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11339295-B2 Oxidative dye couplers with novel auxochrome substituents and azomethine dyes and leuco forms thereof WELLA INTERNATIONAL OPERATIONS SWITZERLAND SÀRL (CH) 2022-05-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11339295-B2 Oxidative dye couplers with novel auxochrome substituents and azomethine dyes and leuco forms thereof CRY1, PPOX, DAO PABPC1 3635/4885MAPT 2475/4885ALDH1A1 1073/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback